Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Regaal Resources IPO opens for subscription ; GMP at 22%. Should you bid ?
12/08/2025
JSW Cement IPO allotment to be finalised today. Check status, GMP and other details
12/08/2025
Asian stocks advance ahead of US inflation data, Nikkei climbs
12/08/2025
Fusion Finance to bet on MSMEs, expects better show in Q3
12/08/2025
Indian equity indices surge 1% amid SBI profit boost and Trump-Putin meeting optimism
12/08/2025
PG Electroplast plummets 35% in 5 days amid weak revenue guidance
12/08/2025
